What is the recommended intravenous (IV) management for an acute severe headache?

IV Management of Acute Severe Headache

For acute severe migraine in the emergency department, use IV prochlorperazine (10 mg) or IV metoclopramide (10 mg) as first-line therapy, with subcutaneous sumatriptan (6 mg) as an alternative; avoid opioids entirely. 1, 2

First-Line IV Therapies (Level A/B Evidence)

The most recent 2025 American Headache Society guideline provides the strongest evidence for ED management 2:

Must Offer (Level A):

• IV Prochlorperazine 10 mg - Multiple class I studies demonstrate high efficacy for acute migraine pain relief 1, 2
  • Add diphenhydramine 25-50 mg IV to prevent akathisia/dystonic reactions
  • Effective within 30-60 minutes

Should Offer (Level B):

• IV Metoclopramide 10 mg - Multiple class I studies support efficacy 1, 2

  • Dual benefit: treats pain AND associated nausea/vomiting
  • Also prevents akathisia risk, though lower than prochlorperazine

• Subcutaneous Sumatriptan 6 mg - Fastest onset of triptan class (15 minutes to peak) 3, 1

  • 70-82% efficacy rate
  • Contraindicated in cardiovascular disease, uncontrolled hypertension

• IV Dexketoprofen or IV Ketorolac - NSAID options for parenteral use 2

  • Ketorolac: 60 mg IM/IV, duration ~6 hours 3
  • Avoid in renal disease, bleeding disorders, pregnancy

Adjunctive Therapy

Add IV Dexamethasone 10 mg to prevent headache recurrence within 24-72 hours (Level B) 1. This does NOT improve immediate pain relief but reduces the likelihood of patients returning to the ED.

Treatments to Avoid

Must NOT offer (Level A):

• IV Hydromorphone - Class I evidence shows it is ineffective and prolongs ED length of stay 2
• Opioids (morphine, meperidine) - Risk of dependency, medication overuse headache, and lack of migraine-specific efficacy 4, 1
• Butalbital-containing compounds - Associated with medication overuse headache 4

May NOT offer (Level C):

• IV Paracetamol (Acetaminophen) - Recent evidence shows ineffectiveness as monotherapy 2

Alternative/Rescue Options

If first-line therapies fail or are contraindicated:

• IV Chlorpromazine (may offer, Level C) - Effective but higher sedation risk 2
• IV Valproate 900-1200 mg (may offer, Level C) - Useful for severe/refractory cases, average response time 50 minutes 5
• Greater Occipital Nerve Block (GONB) - Must offer (Level A) - Non-pharmacologic alternative with high efficacy 2

Clinical Algorithm

1. Confirm migraine diagnosis (not secondary headache requiring neuroimaging)
2. Check contraindications: cardiovascular disease (for triptans), movement disorders (for dopamine antagonists)
3. First-line choice:
   • If nausea/vomiting prominent → IV metoclopramide 10 mg
   • If pure headache → IV prochlorperazine 10 mg + diphenhydramine 25-50 mg
   • If cardiovascular contraindications to above → IV ketorolac 60 mg
4. Add dexamethasone 10 mg IV to all patients to prevent recurrence
5. Reassess at 60 minutes:
   • If inadequate response → Add subcutaneous sumatriptan 6 mg (if not contraindicated)
   • If still refractory → Consider IV valproate or GONB

Critical Pitfalls

• Medication overuse headache threshold: Dopamine antagonists and triptans used >10 days/month can cause rebound headaches 4
• Akathisia risk: Always co-administer diphenhydramine with prochlorperazine; metoclopramide has lower but present risk 3
• Triptan contraindications: Screen for coronary artery disease, uncontrolled hypertension, hemiplegic migraine 3
• Pregnancy: Avoid NSAIDs (especially third trimester), valproate, and ergotamines; metoclopramide is relatively safer 4

Special Populations

Pregnant patients: Metoclopramide + diphenhydramine is the safest IV option; avoid NSAIDs after 20 weeks gestation 4

Patients with frequent ED visits: Consider prophylactic therapy referral if >4 attacks/month; IV eptinezumab (CGRP antagonist) may be offered but requires specific clinical trial population matching 2